Abivax publishes a prospectus in the context of its capital increase and bonds offering

Retrieved on: 2021-07-23 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

Abivax publishes a prospectus in the context of its capital increase and bonds offering. View article details on hiswai:

Excerpt

... (CEST) - Abivax (Euronext Paris: FR0012333284 - ABVX) (the "Company"), a clinical-stage biotechnology company harnessing the immune system ...

Article found on: www.marketscreener.com